SIBPX vs. SHPAX
Compare and contrast key facts about Saratoga Investment Quality Bond Portfolio (SIBPX) and Saratoga Health & Biotechnology Fund (SHPAX).
SIBPX is managed by Saratoga. It was launched on Sep 1, 1994. SHPAX is managed by Saratoga. It was launched on Jul 14, 1999.
Performance
SIBPX vs. SHPAX - Performance Comparison
Loading graphics...
SIBPX vs. SHPAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SIBPX Saratoga Investment Quality Bond Portfolio | -1.04% | 6.50% | 0.78% | 2.90% | -2.51% | -1.73% | 3.34% | 3.84% | -0.72% | -0.13% |
SHPAX Saratoga Health & Biotechnology Fund | -1.13% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -5.30% | 0.71% |
Returns By Period
In the year-to-date period, SIBPX achieves a -1.04% return, which is significantly higher than SHPAX's -1.13% return.
SIBPX
- 1D
- 0.42%
- 1M
- -2.37%
- YTD
- -1.04%
- 6M
- -0.33%
- 1Y
- 2.98%
- 3Y*
- 2.64%
- 5Y*
- 1.02%
- 10Y*
- —
SHPAX
- 1D
- 0.96%
- 1M
- -6.99%
- YTD
- -1.13%
- 6M
- 10.24%
- 1Y
- 12.17%
- 3Y*
- 6.93%
- 5Y*
- 5.73%
- 10Y*
- 6.84%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
SIBPX vs. SHPAX - Expense Ratio Comparison
SIBPX has a 1.54% expense ratio, which is lower than SHPAX's 2.90% expense ratio.
Return for Risk
SIBPX vs. SHPAX — Risk / Return Rank
SIBPX
SHPAX
SIBPX vs. SHPAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Saratoga Investment Quality Bond Portfolio (SIBPX) and Saratoga Health & Biotechnology Fund (SHPAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SIBPX | SHPAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.72 | 0.78 | -0.06 |
Sortino ratioReturn per unit of downside risk | 1.06 | 1.18 | -0.12 |
Omega ratioGain probability vs. loss probability | 1.12 | 1.15 | -0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.27 | 1.56 | -0.29 |
Martin ratioReturn relative to average drawdown | 4.06 | 4.30 | -0.24 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SIBPX | SHPAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.72 | 0.78 | -0.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.31 | 0.41 | -0.09 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.41 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.45 | 0.30 | +0.16 |
Correlation
The correlation between SIBPX and SHPAX is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
SIBPX vs. SHPAX - Dividend Comparison
SIBPX's dividend yield for the trailing twelve months is around 2.20%, less than SHPAX's 3.70% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SIBPX Saratoga Investment Quality Bond Portfolio | 2.20% | 2.24% | 2.31% | 1.54% | 0.14% | 1.39% | 0.58% | 0.99% | 1.21% | 1.03% | 0.00% | 0.00% |
SHPAX Saratoga Health & Biotechnology Fund | 3.70% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
Drawdowns
SIBPX vs. SHPAX - Drawdown Comparison
The maximum SIBPX drawdown since its inception was -5.57%, smaller than the maximum SHPAX drawdown of -69.50%. Use the drawdown chart below to compare losses from any high point for SIBPX and SHPAX.
Loading graphics...
Drawdown Indicators
| SIBPX | SHPAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -5.57% | -69.50% | +63.93% |
Max Drawdown (1Y)Largest decline over 1 year | -2.78% | -7.87% | +5.09% |
Max Drawdown (5Y)Largest decline over 5 years | -4.93% | -16.32% | +11.39% |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.05% | — |
Current DrawdownCurrent decline from peak | -2.37% | -6.99% | +4.62% |
Average DrawdownAverage peak-to-trough decline | -1.70% | -28.07% | +26.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.87% | 2.86% | -1.99% |
Volatility
SIBPX vs. SHPAX - Volatility Comparison
The current volatility for Saratoga Investment Quality Bond Portfolio (SIBPX) is 1.60%, while Saratoga Health & Biotechnology Fund (SHPAX) has a volatility of 4.62%. This indicates that SIBPX experiences smaller price fluctuations and is considered to be less risky than SHPAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SIBPX | SHPAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 1.60% | 4.62% | -3.02% |
Volatility (6M)Calculated over the trailing 6-month period | 2.61% | 9.76% | -7.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 4.30% | 16.57% | -12.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 3.29% | 14.19% | -10.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 2.72% | 16.57% | -13.85% |